# Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma

> **NCT07704918** · NA · RECRUITING · sponsor: **University of Colorado, Denver** · enrollment: 40 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **DRUG:** Statins (atorvastatin, rosuvastatin, simvastatin, or pravastatin), +/- ezetimibe, +/- PCSK9 inhibitor (alirocumab, evolocumab, inclisiran)

## Key facts

- **NCT ID:** NCT07704918
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-12-31
- **Primary completion:** 2027-12
- **Final completion:** 2028-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07704918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07704918, "Aggressive Lipid Lowering Therapy in ICI-Treated Melanoma". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07704918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*